awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q33435310-42AB0E13-B46B-4F84-BAB5-E41FF13D70F6
Q33435310-42AB0E13-B46B-4F84-BAB5-E41FF13D70F6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33435310-42AB0E13-B46B-4F84-BAB5-E41FF13D70F6
C3:CH50 ratio as a proposed composite marker for eculizumab monitoring in atypical hemolytic uremic syndrome: Preliminary results.
P2860
Q33435310-42AB0E13-B46B-4F84-BAB5-E41FF13D70F6
BestRank
Statement
http://www.wikidata.org/entity/statement/Q33435310-42AB0E13-B46B-4F84-BAB5-E41FF13D70F6
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
d5ad0a2625df083467640b554d2dbc87a1f8ce58
P2860
Efficacy and safety of eculizumab in atypical hemolytic uremic syndrome from 2-year extensions of phase 2 studies